Free beta access. 50 free AI tokens each week. Optional top-ups available. See what is included
Opening Word document…

AI is the future of biotech

Catherine Shaffer, 4-1-2020, "Artificial Intelligence Is Helping Biotech Get Real," GEN - Genetic Engineering and Biotechnology News, https://www.genengnews.com/insights/trends-for-2020/artificial-intelligence-is-helping-biotech-get-real/

Artificial intelligence (AI) may sound futuristic, but it already exists in many everyday technologies. For example, it gives our handheld devices voice and facial recognition capabilities. AI is also making its presence felt in biotechnology, where it has become integral to many aspects of drug discovery and development. AI applications in biotech include drug target identification, drug screening, image screening, and predictive modeling. AI is also being used to comb through the scientific literature and manage clinical trial data. By leveraging machine learning, AI can manage disparate clinical trial datasets, enable virtual screening, and analyze vast amounts of data. Besides reducing clinical trial costs, AI can gain otherwise unobtainable insights and feed them back into the drug development process. AI technologies to serve the biotech industry are being developed by several companies. Their services are rapidly becoming indispensable as older methods like classical statistical analysis or manual image scanning reach their practical limits.

Sign in to recut, update, or save this card.